Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Sales | 48,296,000 | 48,418,000 | 48,371,000 | 47,405,000 | 48,988,000 |
| Cost of Goods | 8,112,000 | 11,239,000 | 7,640,000 | 7,232,000 | 6,391,000 |
| Gross Profit | 40,184,000 | 37,179,000 | 40,731,000 | 40,173,000 | 42,597,000 |
| Operating Expenses | 28,458,000 | 29,660,000 | 28,607,000 | 28,976,000 | 28,391,000 |
| Operating Income | 11,726,000 | 7,519,000 | 12,124,000 | 11,197,000 | 14,206,000 |
| Other Income | -2,032,000 | 1,759,000 | 904,000 | -397,000 | -803,000 |
| Pre-tax Income | 9,694,000 | 9,278,000 | 13,028,000 | 10,800,000 | 13,403,000 |
| Income Tax | 1,645,000 | 1,023,000 | 1,992,000 | 3,178,000 | 2,460,000 |
| Net Income Continuous | 8,049,000 | 8,255,000 | 11,024,000 | 7,610,000 | 10,936,000 |
| Net Income Discontinuous | 78,000 | -69,000 | 8,313,000 | 498,000 | 425,000 |
| Minority Interests | 23,000 | 42,000 | N/A | N/A | N/A |
| Net Income | $8,104,000 | $8,144,000 | $19,337,000 | $8,085,000 | $11,361,000 |
| EPS Basic Total Ops | 1.20 | 1.18 | 2.67 | 1.10 | 1.51 |
| EPS Basic Continuous Ops | 1.19 | 1.19 | 1.52 | 1.03 | 1.45 |
| EPS Basic Discontinuous Ops | 0.01 | -0.01 | 1.15 | 0.07 | 0.06 |
| EPS Diluted Total Ops | 1.20 | 1.17 | 2.66 | 1.09 | 1.49 |
| EPS Diluted Continuous Ops | 1.19 | 1.18 | 1.52 | 1.02 | 1.43 |
| EPS Diluted Discontinuous Ops | 0.01 | -0.01 | 1.14 | 0.07 | 0.06 |
| EBITDA(a) | $16,816,000 | $12,719,000 | $17,417,000 | $16,773,000 | $19,299,000 |